Brief: Pieris Pharmaceuticals Says Quarterly Net Loss Was $10.3 Mln

Palvella Therapeutics

04/08/2022 12:44

Aug 4 (Reuters) - Pieris Pharmaceuticals Inc  PIRS.O :
    * PIERIS PHARMACEUTICALS INC -  STRATEGIC PIPELINE
PRIORITIZATION
RESULTS IN CASH REACH TO THE SECOND QUARTER OF 2024
    * PIERIS PHARMACEUTICALS INC -  CASH, CASH EQUIVALENTS, AND
INVESTMENTS TOTALED $80.9 MILLION FOR THE QUARTER ENDED JUNE 30,
2022
    * PIERIS PHARMACEUTICALS INC -  NET LOSS WAS $10.3 MILLION
OR
$0.14 PER SHARE FOR THE QUARTER ENDED JUNE 30, 2022

Further company coverage:  PIRS.O 

 ((Reuters.Briefs@thomsonreuters.com;))